Goodwin Procter advised Wave Life Sciences on the deal.Wave Life Sciences (Nasdaq: WVE) announced its strategic collaboration with GSK (LSE/NYSE: GSK) to advance oligonucleotide therapeutics, including Wave’s…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
